Evidence map›Paper›PMID 34778015›Full record

ArticlePublic health action2021

Prevalence of methicillin-resistant

P Pradhan, P Rajbhandari, S B Nagaraja, P Shrestha, R Grigoryan, S Satyanarayana, H Davtyan

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Public health action, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Global prevalence of macrolide-resistantFrontiers in microbiology · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Iranian journal of microbiology · 2025
    Article
  11. In Vivo Effect of Halicin on Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2024
    Article
  12. Review
  13. Article
  14. Observational
  15. Methicillin-Resistant and Biofilm-ProducingThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

P PradhanDepartment of Medical Microbiology and Immunology, Patan Academy of Health Sciences, Lalitpur, Nepal.
P RajbhandariDepartment of Medical Microbiology and Immunology, Patan Academy of Health Sciences, Lalitpur, Nepal.
S B NagarajaDepartment of Community Medicine, ESIC Medical College and Post Graduate Institute of Medical Science and Research, Bangalore, India.
P ShresthaWorld Health Organization Health Emergencies Programme, Kathmandu, Nepal.
R GrigoryanTuberculosis Research and Prevention Center, Yerevan, Armenia.
S SatyanarayanaCentre for Operational Research, International Union Against Tuberculosis and Lung Disease, Paris, France.
H DavtyanTuberculosis Research and Prevention Center, Yerevan, Armenia.
Patan Academy of Health Sciences · NPESI - Post Graduate Institute of Medical Science and Research · INInternational Union Against Tuberculosis and Lung Disease · FR

Funding

World Health Organization 001
6 · The paper itself

Abstract

settingPatan Hospital, Lalitpur, Nepal.

objectivesTo describe 1) the prevalence of methicillin-resistant

designThis was a cross-sectional study using electronic and paper-based hospital records of patients with

resultsOf the 1,804 patients with

conclusionMore than 50% of patients with

Indexed as

antibiotic sensitivity patternMRSANepalprevalencetreatment outcome

Identifiers

PMID34778015
PMCPMC8575383
OpenAlexW3214552254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.